Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-59,900
Closed -$4.04M 1111
2025
Q3
$4.04M Buy
59,900
+20,000
+50% +$1.33M 0.84% 27
2025
Q2
$2.6M Buy
+39,900
New +$2.39M 0.5% 38
2019
Q2
Sell
-500
Closed -$2.42M 351
2019
Q1
$2.42M Buy
+500
New +$22.5K 0.44% 46

Other funds holding HOLX

Summit Securities Group's HOLX Position: Q1 2026 in Review

Summit Securities Group reduced its Hologic (HOLX) stake by 89% in Q1 2026, selling an estimated $22.2K and leaving 36 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Summit Securities Group first reported a position in HOLX in Q1 2022 and has held it in 10 quarters since. The position peaked at $93.4K in Q3 2025. 703 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Summit Securities Group held 36 shares of Hologic worth $2.72K as of Q1 2026.
  • Summit Securities Group sold 295 Hologic shares in Q1 2026, an estimated $22.2K.
  • Hologic made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #902 holding.
  • Summit Securities Group first reported a position in Hologic in Q1 2022 and has held it in 10 quarters since.
  • Summit Securities Group's Hologic position peaked at $93.4K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.